Varun Pandey, PhD
Senior Director, Medical Information & Medical Affairs Strategic Operations
Expertise:
Varun is a seasoned professional with over a decade of expertise in scientific research and medical communications, spanning both academia and the pharmaceutical industry. His extensive background includes leadership roles in scientific publications and medical information content development. Varun has played a pivotal role as a medical reviewer for a diverse range of medical communication deliverables, serving top pharmaceutical clients across various therapeutic areas. His commitment to maintaining high precision, superior quality, data accuracy, scientific rigor, language consistency, and overall aesthetic appeal is unwavering. Moreover, Varun’s extensive experience in leading scientific writing teams demonstrates his ability to orchestrate data fact-checking and medical reviews efficiently. His strategic acumen shines through in resource allocation and meticulous planning to ensure the timely delivery of review services, synchronized with major global conferences like ASCO, ESMO, AHA, ADA, ACC, and ERS.
Articles by Varun Pandey, PhD
Enhancing Medical Strategies Through Effective Literature Surveillance
Members from EVERSANA’s Medical Affairs (MA) team conducted a comprehensive survey to understand the needs of MA professionals regarding literature surveillance, reviews and alerts. They presented their findings at the DIA Medical Affairs and Scientific Communications Forum in March 2025. Their survey was distributed to MA professionals via LinkedIn and covered various topics related to […]
Revolutionizing Customer Experience: The Role of AI in Enhancing MI Contact Center Operations
At the 2025 DIA Medical Affairs and Scientific Communications Forum, experts from EVERSANA gave a presentation on the transformative role of AI in enhancing Medical Information (MI) Contact Center operations and its primary objective – to improve customer experience and operational efficiency within the pharmaceutical industry through the integration of AI and advanced automation. The […]
The Evolving Landscape of HCP Engagement and the Role of Medical Information in This Era of Digital Innovation
This poster delves into the dynamic landscape of HCP engagement and the pivotal role of Medical Information (MI). It underscores the significance of effective HCP engagement for enhancing clinical decision-making and patient outcomes and emphasizes the cruciality of access to short, reliable, and personalized content across diverse digital channels and independent websites. To address these […]
Considerations for the Development of Interactive / Innovative Medical Information Content – Insights from a Service Provider
The creation of high-quality, customer-centric medical information (MI) content accessible through various data dissemination channels is crucial. EVERSANA, a provider of global MI contact center services, has embarked on developing more interactive MI content. This initiative involves converting traditional SRDs and FAQs into engaging and innovative formats by identifying considerations essential for this format of […]
Current Trends in Medical Review of Promotional and Non-Promotional Materials
Medical Information (MI) plays a crucial role in addressing inquiries from healthcare professionals, payors, and patients/caregivers and ensuring pharmaceutical products’ safe, effective, and appropriate use. However, MI teams often have other important responsibilities beyond the scope of traditional MI services. EVERSANA conducted a survey in 2023 to assess current trends and to better understand Medical […]
Considerations for Globalization of Medical Information Services: A Service Partner Perspective
This poster details the considerations for globalizing medical information (MI) services. Traditionally, pharmaceutical companies began in one geographical region before expanding, but evolving regulations and research priorities for rare diseases, oncology/hematology, immunology, and cell and gene therapy have led to simultaneous global regulatory filings. To streamline operations and maintain control, these companies partner with global […]